SOLID TARGET TECHNOLOGY FOR MEDICAL CYCLOTRONS
ARTMS™ Products is a leader in the development of novel technologies which enable the production of the world’s most-used diagnostic imaging isotopes. Our flagship product is the QUANTM99, a hardware and consumable system for producing Tc-99m on medical cyclotrons to enable cost-effective, decentralized, and local production of medical isotopes.
In 2007 & 2009 the world experienced shortages due to reactor outages, highlighting the vulnerability of the current supply chain. The shortages caused in significant price increases, delayed and canceled medical procedures and resulted in a decrease in patient care. In response, ARTMS Products Inc. developed an award-winning, first-to-market, locally deployable method for producing Tc-99m using existing, hospital-based medical cyclotrons. ARTMS holds the exclusive global commercialization rights to the award-winning and proprietary Canadian technology that addresses these challenges and offers the prospect of revolutionizing the nuclear medicine industry.
IN THE NEWS
Researchers at the BC Cancer Agency in Vancouver and TRIUMF, the Canadian national particle and nuclear physics lab, have successfully produced vital supplies of Technetium-99m, a medical imaging isotope, using a retrofitted cyclotron, a type of particle accelerator already in […]
A Canadian-led team says that it has succeeded in proving the feasibility of using particle accelerators instead of nuclear reactors to produce a badly needed medical isotope. If health regulators approve the method, it will place supplies of the crucial […]
The first commercial shipment of medical isotopes produced using a new particle-accelerator-based technique has been made by scientists at the Canadian Light Source (CLS). Molybdenum-99 (Mo-99) decays to create technetium-99m (Tc-99m), which is used to tag radiopharmaceuticals and plays a […]
Dr. Paul Schaffer, along with five other distinguished colleagues, received the prestigious NSERC Brockhouse Canada Prize for outstanding interdisciplinary research advancing diagnostic imaging isotope production. The annual Prize was awarded by His Excellency the Right Honourable David Johnston, the 28th Governor General of Canada.